Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Mr. Stylianos Valiantis

Stylianos Valiantis, BSc, MSc

Ph.D. Student

Stylianos holds a B.Sc. in Psychology from Aristotle University of Thessaloniki, Greece, an M.Sc. in Neuroscience from Cyprus Institute of Neurology and Genetics in Nicosia, Cyprus, and is currently a Ph.D. student in Clinical Psychology at the University of Cyprus in Nicosia, Cyprus.

His Ph.D. research project focuses on nicotine relapse vulnerability, specifically involving the investigation of neurobiophysiological markers to better understand the associated risks.

Research Interests: His research interests primarily revolve around the study of brain-behavior relationships, particularly focusing on behavioral expressions as an indicator of nervous system pathology. He has been involved in various projects that examine behavioral and neuroendocrine responses to different conditions, including enriched environments and stressful events, with the aim of identifying mechanisms associated with mental disorders like anxiety and depression. These projects involved the use of animal models, which underwent both histological and behavioral tests. Additionally, he has been part of a project that investigates the impact of Alzheimer’s Disease-derived brain pathology on fine motor function. This research involved the use of transgenic animal models and various techniques, including PCR and behavioral analyses, to draw conclusions regarding the disturbance of fine motor function observed in this disorder.

Contact Info:

Email: valiantis.stylianos@ucy.ac.cy

Recent Posts

  • Zanos lab publishes a short review article on Major Depressive Disorder in Trends in Molecular Medicine January 4, 2026
  • Dr. Zanos appointed as science communication coordinator for European psychedelics research network December 30, 2025
  • Dr. Anna Onisiforou secures €100,000 ERC Vision funding for Multiple Sclerosis research December 24, 2025
  • Zanos Lab research on ketamine’s therapeutic mechanisms in depression and Opioid Use Disorder was presented in a seminar at the University of Haifa December 18, 2025
  • Our Ph.D. student, Despina Melanthiou, featured in national newspaper article on Misophonia research December 14, 2025

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress